Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13703) 13703
Book Review (3349) 3349
Publication (1023) 1023
Book Chapter (227) 227
Conference Proceeding (77) 77
Reference (38) 38
Dissertation (22) 22
Magazine Article (9) 9
Book / eBook (6) 6
Government Document (4) 4
Web Resource (4) 4
Data Set (3) 3
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9841) 9841
humans (7540) 7540
serotonin reuptake inhibitors (5891) 5891
psychiatry (4888) 4888
male (4661) 4661
pharmacology & pharmacy (4429) 4429
female (4167) 4167
antidepressants (3481) 3481
animals (3008) 3008
neurosciences (2953) 2953
depression (2927) 2927
adult (2799) 2799
serotonin (2172) 2172
double-blind (2079) 2079
fluoxetine (2069) 2069
middle aged (2045) 2045
serotonin uptake inhibitors - therapeutic use (2008) 2008
antidepressive agents - therapeutic use (1845) 1845
clinical neurology (1749) 1749
major depression (1661) 1661
selective serotonin reuptake inhibitors (1656) 1656
rats (1480) 1480
treatment outcome (1462) 1462
major depressive disorder (1346) 1346
aged (1338) 1338
serotonin uptake inhibitors - adverse effects (1264) 1264
serotonin uptake inhibitors - pharmacology (1185) 1185
reuptake inhibitors (1149) 1149
adolescent (1132) 1132
paroxetine (1126) 1126
depressive disorder - drug therapy (1105) 1105
antidepressant (1043) 1043
depressive disorder, major - drug therapy (1037) 1037
dose-response relationship, drug (1034) 1034
serotonin uptake inhibitors (1015) 1015
antidepressive agents - adverse effects (1011) 1011
placebo-controlled trial (1003) 1003
drug therapy (988) 988
obsessive-compulsive disorder (946) 946
selective serotonin reuptake inhibitor (939) 939
analysis (923) 923
depression, mental (907) 907
efficacy (896) 896
pregnancy (880) 880
risk factors (868) 868
tricyclic antidepressants (858) 858
anxiety (853) 853
depression - drug therapy (844) 844
serotonin-reuptake inhibitors (789) 789
citalopram (781) 781
sertraline (775) 775
mice (767) 767
risk (758) 758
drugs (725) 725
double-blind method (719) 719
antidepressive agents - pharmacology (712) 712
mental depression (685) 685
research (677) 677
care and treatment (659) 659
medicine & public health (651) 651
metaanalysis (651) 651
rats, sprague-dawley (650) 650
drug interactions (633) 633
serotonin - metabolism (633) 633
medicine, general & internal (630) 630
serotonin reuptake inhibitor (621) 621
venlafaxine (615) 615
young adult (604) 604
serotonin uptake inhibitors - administration & dosage (590) 590
brain (582) 582
fluvoxamine (582) 582
reuptake inhibitor (567) 567
time factors (565) 565
article (563) 563
child (552) 552
psychiatric status rating scales (548) 548
pharmacology (547) 547
abridged index medicus (544) 544
pharmacotherapy (543) 543
drug therapy, combination (536) 536
ssri (531) 531
dopamine (529) 529
children (526) 526
psychology, clinical (516) 516
fluoxetine - pharmacology (514) 514
health aspects (508) 508
placebo (505) 505
psychology (494) 494
psychopharmacology (489) 489
pharmacokinetics (484) 484
antidepressive agents, second-generation - therapeutic use (470) 470
comorbidity (470) 470
toxicology (442) 442
prevalence (432) 432
disease models, animal (426) 426
neurology (425) 425
norepinephrine (425) 425
pharmacology/toxicology (423) 423
phenols (423) 423
randomized controlled trials as topic (415) 415
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13340) 13340
German (260) 260
French (160) 160
Spanish (63) 63
Japanese (41) 41
Italian (39) 39
Portuguese (36) 36
Turkish (36) 36
Russian (25) 25
Polish (12) 12
Dutch (11) 11
Korean (10) 10
Czech (8) 8
Chinese (7) 7
Danish (4) 4
Icelandic (4) 4
Croatian (2) 2
Hungarian (2) 2
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis
by Locher, Cosima and Koechlin, Helen and Zion, Sean R and Werner, Christoph and Pine, Daniel S and Kirsch, Irving and Kessler, Ronald C and Kossowsky, Joe
JAMA Psychiatry, ISSN 2168-622X, 10/2017, Volume 74, Issue 10, pp. 1011 - 1020
IMPORTANCE: Depressive disorders (DDs), anxiety disorders (ADs), obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD) are common... 
CONTROLLED-TRIAL | FLUOXETINE TREATMENT | GENERALIZED ANXIETY DISORDER | PAROXETINE TREATMENT | PSYCHIATRY | COGNITIVE-BEHAVIORAL THERAPY | DOUBLE-BLIND EFFICACY | CLINICAL-TRIALS | VENLAFAXINE ER | MAJOR DEPRESSIVE DISORDER | OBSESSIVE-COMPULSIVE DISORDER | Serotonin and Noradrenaline Reuptake Inhibitors - pharmacology | Mental Disorders - drug therapy | Humans | Adolescent | Female | Male | Treatment Outcome | Serotonin Uptake Inhibitors - pharmacology | Child | Treatment outcome | Care and treatment | Usage | Safety and security measures | Serotonin | Analysis | Placebos | Dosage and administration | Anxiety | Index Medicus | Abridged Index Medicus | Depressive Disorders | SSRIs | Systematic Review | Males | PTSD | Anxiety Disorders | Treatment Effectiveness | Obsessive-Compulsive Disorder | Suicidality | SNRIs | Evidence Based Treatment | Meta Analysis | Children | Adolescents | Females | Negative Therapeutic Reaction | Online First | Original Investigation | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Cerebrovascular, cardiovascular, and mortality events in new users of selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors: A propensity score-matched population-based study
by Leong, Christine and Alessi-Severini, Silvia and Enns, Murray W and Nie, Yao and Sareen, Jitender and Bolton, James and Prior, Heather J and Chateau, Dan
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 2017, Volume 37, Issue 3, pp. 332 - 340
Background: Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) are widely prescribed for mood and anxiety... 
Pharmacoepidemiology | Cardiovascular events | Death | Cerebrovascular events | Serotonin norepinephrine reuptake inhibitors | cardiovascular events | METAANALYSIS | death | PSYCHIATRY | serotonin norepinephrine reuptake inhibitors | RISK | BLOOD-PRESSURE | pharmacoepidemiology | VENLAFAXINE | STROKE | PHARMACOLOGY & PHARMACY | cerebrovascular events | MAJOR DEPRESSIVE DISORDER | ANTIDEPRESSANT USE | HEALTHY-VOLUNTEERS | NORADRENALINE | EPIDEMIOLOGY | Mood Disorders - drug therapy | Myocardial Infarction - chemically induced | Serotonin and Noradrenaline Reuptake Inhibitors - adverse effects | Myocardial Infarction - mortality | Follow-Up Studies | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Mood Disorders - epidemiology | Young Adult | Stroke - chemically induced | Aged, 80 and over | Cardiovascular Diseases - mortality | Adult | Female | Retrospective Studies | Anxiety Disorders - drug therapy | Stroke - mortality | Child | Cerebrovascular Disorders - chemically induced | Manitoba - epidemiology | Serotonin Uptake Inhibitors - adverse effects | Anxiety Disorders - epidemiology | Cerebrovascular Disorders - mortality | Propensity Score | Adolescent | Aged | Cardiovascular Diseases - chemically induced | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Comparative efficacy and safety of phosphodiesterase-5 inhibitors with selective serotonin reuptake inhibitors in men with premature ejaculation: A systematic review and Bayesian network meta-analysis
by Jin, Kun and Deng, Linghui and Qiu, Shi and Tu, Xiang and Li, Jiakun and Bao, Yige and Yang, Lu and Wei, Qiang
Medicine, ISSN 0025-7974, 12/2018, Volume 97, Issue 49, pp. e13342 - e13342
We performed the network meta-analysis (NMA) and systematic review involved all evidence from relevant trials to compare the efficiency and safety of various... 
Premature ejaculation | Paroxetine | Tadalafil | Enzyme inhibitors | Patient outcomes | Dosage and administration | Sildenafil | Drug therapy | Comparative analysis | Sertraline | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. The diagnostic clinical interview for drug withdrawal 1 (DID-W1) New symptoms of selective serotonin reuptake inhibitors (SSRI) or serotonin norepinephrine reuptake inhibitors (SNRI): Inter-rater reliability
by Cosci, Fiammetta and Chouinard, Guy and Chouinard, Virginie-Anne and Fava, Giovanni Andrea
Rivista di Psichiatria, ISSN 0035-6484, 03/2018, Volume 53, Issue 2, pp. 95 - 99
Aim. A wide range of clinical phenomena have been reported with dose reduction or drug discontinuation of Selective Serotonin Reuptake Inhibitors (SSRIs) or... 
Reliability | Withdrawal | Serotonin norepinephrine reuptake inhibitor | Iatrogenic comorbidity | Interview | Selective serotonin reuptake inhibitor | DEPRESSION | ANTIDEPRESSANT | PANIC DISORDER | SAFETY | PSYCHIATRY | DISCONTINUATION SYNDROME | reliability | serotonin norepinephrine reuptake inhibitor | iatrogenic comorbidity | IATROGENIC-COMORBIDITY | withdrawal | selective serotonin reuptake inhibitor | PSYCHOSIS | PAROXETINE | SCALE | interview | Adrenergic Uptake Inhibitors - adverse effects | Adrenergic Uptake Inhibitors - therapeutic use | Substance Withdrawal Syndrome - etiology | Humans | Middle Aged | Serotonin Uptake Inhibitors - therapeutic use | Symptom Assessment | Serotonin Uptake Inhibitors - adverse effects | Male | Mental Disorders - psychology | Norepinephrine - metabolism | Outpatients - psychology | Mental Disorders - drug therapy | Serotonin - metabolism | Adult | Female | Interview, Psychological | Observer Variation | Substance Withdrawal Syndrome - diagnosis
Journal Article
Details down arrow
5. Full Text Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs)
by Matchar, David B and United States. Agency for Healthcare Research and Quality and Duke University Evidence-based Practice Center
2006, Evidence report/technology assessment, Volume no. 146.
Serotonin uptake inhibitors | Metabolism | Cytochrome P-450 | Testing
eBook
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text High‐performance liquid chromatography with diode array detection method for the simultaneous determination of seven selected phosphodiesterase‐5 inhibitors and serotonin reuptake inhibitors used as male sexual enhancers
by Baker, Mostafa M and Belal, Tarek S and Mahrous, Mohamed S and Ahmed, Hytham M and Daabees, Hoda G
Journal of Separation Science, ISSN 1615-9306, 05/2016, Volume 39, Issue 9, pp. 1656 - 1665
This work presents a simple, sensitive and generic high‐performance liquid chromatography with diode array detection method for the simultaneous determination... 
Selective serotonin reuptake inhibitors | Diode array detection | Phosphodiesterase‐5 inhibitors | Tablet dosage forms | High‐performance liquid chromatography | Phosphodiesterase-5 inhibitors | High-performance liquid chromatography | CHEMISTRY, ANALYTICAL | METABOLITES | SILDENAFIL | PREMATURE EJACULATION | TADALAFIL | ANTIDEPRESSANTS | VARDENAFIL | THERAPY | PLASMA | ERECTILE DYSFUNCTION | DAPOXETINE | Phosphates | Paroxetine | Fluoxetine | Analysis | Phenols | Nitriles | Sexual disorders | High performance liquid chromatography | Methods | Enzymes | Pharmacology | Serotonin | Chromatography | Index Medicus | Drugs | Inhibitors | Linearity | Sildenafil | Arrays | Diodes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Before Prozac
: the troubled history of mood disorders in psychiatry
by Shorter, Edward
2009, ISBN 9780195368741, xvi, 304
Book
Details down arrow
8. Full Text Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors—Part 2
by Yukawa, Tomoya and Fujimori, Ikuo and Kamei, Taku and Nakada, Yoshihisa and Sakauchi, Nobuki and Yamada, Masami and Ohba, Yusuke and Ueno, Hiroyuki and Takiguchi, Maiko and Kuno, Masako and Kamo, Izumi and Nakagawa, Hideyuki and Fujioka, Yasushi and Igari, Tomoko and Ishichi, Yuji and Tsukamoto, Tetsuya
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 07/2016, Volume 24, Issue 14, pp. 3207 - 3217
Peripherally selective inhibition of noradrenaline reuptake is a novel mechanism for the treatment of stress urinary incontinence to overcome adverse effects... 
MDR1 efflux ratio | Deuterium replacement | Peripheral-selective noradrenaline reuptake inhibitor | Stress urinary incontinence | Genetic polymorphism | Peripheral-selective noradrenaline reuptake | inhibitor | ANTIDEPRESSANT | CHEMISTRY, MEDICINAL | ASSAY | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC | REBOXETINE | RISK | FIBROMYALGIA | URETHRA | Neurotransmitter Uptake Inhibitors - chemical synthesis | Cricetinae | Cricetulus | Humans | Neurotransmitter Uptake Inhibitors - pharmacology | Rats | Structure-Activity Relationship | Animals | Norepinephrine - metabolism | Neurotransmitter Uptake Inhibitors - chemistry | Drug Design | Cytochrome P-450 CYP2D6 - metabolism | Cytochrome P-450 CYP2C19 - metabolism | Drug Evaluation, Preclinical | CHO Cells | Noradrenaline | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Triple reuptake inhibitors: Design, synthesis and structure–activity relationship of benzylpiperidine–tetrazoles
by Paudel, Suresh and Min, Xiao and Acharya, Srijan and Khadka, Daulat Bikram and Yoon, Goo and Kim, Kyeong-Man and Cheon, Seung Hoon
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 10/2017, Volume 25, Issue 20, pp. 5278 - 5289
Monoamine transporters are important targets in the treatment of various central nervous disorders. Several limitations of traditional reuptake inhibitors,... 
Docking | Norepinephrine and dopamine reuptake inhibitors | Monoamine neurotransmitters | Serotonin | Benzylpiperidine–tetrazoles | NEUROTRANSMITTER TRANSPORTERS | CHEMISTRY, MEDICINAL | NOREPINEPHRINE | Benzylpiperidine-tetrazoles | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC | DUAL SEROTONIN | MAJOR DEPRESSIVE DISORDER | Norepinephrine - antagonists & inhibitors | Neurotransmitter Uptake Inhibitors - chemical synthesis | Piperidines - chemistry | Tetrazoles - chemical synthesis | Tetrazoles - pharmacology | Humans | Neurotransmitter Uptake Inhibitors - pharmacology | Structure-Activity Relationship | Piperidines - chemical synthesis | Dose-Response Relationship, Drug | Norepinephrine - metabolism | Piperidines - pharmacology | Tetrazoles - chemistry | Neurotransmitter Uptake Inhibitors - chemistry | Serotonin - metabolism | Drug Design | Molecular Docking Simulation | Molecular Structure | Dopamine - metabolism | Drugstores | Research institutes | Noradrenaline | Sexual disorders | Pharmacy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Exploration of substituted arylpiperazine–tetrazoles as promising dual norepinephrine and dopamine reuptake inhibitors
by Paudel, Suresh and Acharya, Srijan and Yoon, Goo and Kim, Kyeong-Man and Cheon, Seung Hoon
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 11/2016, Volume 24, Issue 21, pp. 5546 - 5555
In the search for potent dual norepinephrine and dopamine reuptake inhibitors, several substituted arylpiperazine–tetrazoles were designed, synthesized and... 
Norepinephrine reuptake inhibitors | Selective norepinephrine and dopamine reuptake inhibitors | Dopamine reuptake inhibitors | Arylpiperazine–tetrazoles | ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER | ANTIDEPRESSANT | DESIGN | CHEMISTRY, MEDICINAL | DEFICIT HYPERACTIVITY DISORDER | BIOCHEMISTRY & MOLECULAR BIOLOGY | SYNAPTOSOMES | CHEMISTRY, ORGANIC | CHILDREN | HEMOLYTIC-ANEMIA | BUPROPION | NOMIFENSINE | SEROTONIN | Arylpiperazine-tetrazoles | Norepinephrine - antagonists & inhibitors | Tetrazoles - chemical synthesis | Tetrazoles - pharmacology | Humans | Piperazines - chemistry | Structure-Activity Relationship | Piperazines - pharmacology | Dose-Response Relationship, Drug | Norepinephrine - metabolism | Tetrazoles - chemistry | HEK293 Cells | Piperazines - chemical synthesis | Molecular Structure | Dopamine - metabolism | Phenols | Drugstores | Nervous system diseases | Dopamine | Noradrenaline | Pharmacy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials
by Huang, Kai-Lin and Lu, Wan-Chen and Wang, Ying-Yue and Hu, Gwo-Chi and Lu, Chien-Hung and Lee, Wei-Ying and Hsu, Chien-Chi
Australian & New Zealand Journal of Psychiatry, ISSN 0004-8674, 7/2014, Volume 48, Issue 7, pp. 663 - 671
Objective: Agomelatine is a new antidepressant with unique melatonin receptor type 1A (MTNR1A) and 1B ( MTNR1B) agonism and serotonergic receptor... 
meta-analysis | major depressive disorder | agomelatine | safety | Acceptability | efficacy | PSYCHIATRY | ANTIDEPRESSANT AGOMELATINE | SUBJECTIVE SLEEP | FLUOXETINE | ANHEDONIA | TOLERABILITY | DOUBLE-BLIND | ESCITALOPRAM | POOLED ANALYSIS | ANXIETY SYMPTOMS | Serotonin and Noradrenaline Reuptake Inhibitors - adverse effects | Humans | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Male | Treatment Outcome | Randomized Controlled Trials as Topic | Antidepressive Agents - therapeutic use | Psychiatric Status Rating Scales | Acetamides - therapeutic use | Acetamides - adverse effects | Adult | Female | Serotonin and Noradrenaline Reuptake Inhibitors - therapeutic use | Depressive Disorder, Major - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain
by Lucas, Matthew C and Weikert, Robert J and Carter, David S and Cai, Hai-Ying and Greenhouse, Robert and Iyer, Pravin S and Lin, Clara J and Lee, Eun Kyung and Madera, Ann Marie and Moore, Amy and Ozboya, Kerem and Schoenfeld, Ryan C and Steiner, Sandra and Zhai, Yansheng and Lynch, Stephen M
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 2010, Volume 20, Issue 18, pp. 5559 - 5566
Two new series of monoamine triple reuptake inhibitors (TRIs) have been discovered through scaffold homologation of our recently reported series of... 
Triple reuptake inhibitor | Dopamine | Serotonin | Monoamine reuptake inhibitors | Depression | Norepinephrine | Noradrenalin | Major depressive disorder | CHEMISTRY, MEDICINAL | SSRIS | CHEMISTRY, ORGANIC | NEXT-GENERATION | Serotonin Uptake Inhibitors - pharmacokinetics | Neurotransmitter Uptake Inhibitors - pharmacokinetics | Antidepressive Agents, Tricyclic - pharmacokinetics | Humans | Neurotransmitter Uptake Inhibitors - pharmacology | Dopamine Uptake Inhibitors - pharmacokinetics | Serotonin Uptake Inhibitors - chemical synthesis | Antidepressive Agents, Tricyclic - chemistry | Pyrrolidines - pharmacology | Depression - drug therapy | Pain - drug therapy | Drug Design | Dopamine Uptake Inhibitors - chemical synthesis | Dopamine - metabolism | Caco-2 Cells | Neurotransmitter Uptake Inhibitors - chemical synthesis | Dopamine Uptake Inhibitors - pharmacology | Pyrrolidines - pharmacokinetics | Rats | Serotonin Uptake Inhibitors - chemistry | Pyrrolidines - chemistry | Animals | Norepinephrine - metabolism | Antidepressive Agents, Tricyclic - chemical synthesis | Pyrrolidines - chemical synthesis | Antidepressive Agents, Tricyclic - pharmacology | Neurotransmitter Uptake Inhibitors - chemistry | Serotonin - metabolism | Dopamine Uptake Inhibitors - chemistry | Serotonin Uptake Inhibitors - pharmacology | Analysis | Depression, Mental | Electric utilities | Health aspects | Noradrenaline | Atmospheric carbon dioxide | Index Medicus | Brain
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Neurocognitive Changes in Selective Serotonin Reuptake Inhibitors—Treated Adolescents with Depression
by Shehab, Al Amira Safa and Brent, David and Maalouf, Fadi T
Journal of Child and Adolescent Psychopharmacology, ISSN 1044-5463, 10/2016, Volume 26, Issue 8, pp. 713 - 720
Objectives: Adolescents with major depressive disorder (MDD) were found to have deficits in executive function, attention, and memory. Despite the fact that... 
Original Articles | selective serotonin reuptake inhibitor | major depressive disorder | visual memory | adolescents | sustained attention | executive function | Memory - drug effects | Depressive Disorder, Major - physiopathology | Follow-Up Studies | Humans | Serotonin Uptake Inhibitors - therapeutic use | Male | Cognition - drug effects | Case-Control Studies | Neuropsychological Tests | Time Factors | Adolescent | Attention - drug effects | Female | Fluoxetine - therapeutic use | Child | Longitudinal Studies | Depressive Disorder, Major - drug therapy | Executive Function - drug effects | Psychological aspects | Usage | Serotonin agents | Antidepressants | Youth | Dosage and administration | Teenagers | Cognition & reasoning | Mental depression | Children & youth | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. SSRIs in depression and anxiety
by Montgomery, S. A and Boer, Johan A. den, 1953
2001, 2nd ed., Perspectives in psychiatry, ISBN 9780470841365, Volume 8, viii, 216
SSRIs have been used as an effective treatment for depression for many years, but have recently become more widely used in the treatment of many other... 
Chemotherapy | Anxiety Disorders | drug therapy | Depression, Mental | Serotonin uptake inhibitors | Anxiety | Depressive Disorder | therapeutic use | Depression, Mental - Chemotherapy
Book
Details down arrow
15. Full Text Selective Serotonin Reuptake Inhibitor/ Serotonin-Norepinephrine Reuptake Inhibitor Use as a Predictor of a Diagnosis of Restless Legs Syndrome
by Bailey, Anne L and Makela, Eugene H and Asberg, Kia
Journal of Psychiatric Practice, ISSN 1527-4160, 07/2016, Volume 22, Issue 4, pp. 263 - 269
Objective/Background: Because restless legs syndrome (RLS) is a problematic syndrome, demonstrating an association between use of selective serotonin reuptake... 
selective serotonin reuptake inhibitor | serotonin-norepinephrine reuptake inhibitor | restless legs syndrome | LIMB MOVEMENT-DISORDER | MANAGEMENT | PSYCHIATRY | SYMPTOMS | PREVALENCE | FLUOXETINE | GENERAL-POPULATION | QUALITY-OF-LIFE | HEALTH | INDUCED AKATHISIA | EPIDEMIOLOGY | Restless Legs Syndrome - diagnosis | Serotonin and Noradrenaline Reuptake Inhibitors - adverse effects | Prognosis | Humans | Middle Aged | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Male | Restless Legs Syndrome - chemically induced | Adult | Female | Retrospective Studies | Serotonin and Noradrenaline Reuptake Inhibitors - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Should we prescribe selective serotonergic reuptake inhibitors/serotonergic and noradrenergic reuptake inhibitors in the ICU?
by Gerstenblith, Ted-Avi and Bienvenu, O. Joseph
Critical Care Medicine, ISSN 0090-3493, 2017, Volume 45, Issue 6, pp. 1108 - 1109
Antidepressant | Critical care | Intensive care | Serotonin and norepinephrine reuptake inhibitor | Selective serotonin reuptake inhibitor | serotonin and norepinephrine reuptake inhibitor | selective serotonin reuptake inhibitor | ANTIDEPRESSANTS | intensive care | DRUG-INTERACTIONS | antidepressant | critical care | RISK | CRITICAL CARE MEDICINE | Intensive Care Units | Adrenergic Uptake Inhibitors | Serotonin | Humans | Critical Care | Norepinephrine | Serotonin Uptake Inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study
by Malm, Heli, MD, PhD and Brown, Alan S., MD and Gissler, Mika, PhD and Gyllenberg, David, MD, PhD and Hinkka-Yli-Salomäki, Susanna, PhLic and McKeague, Ian W., PhD and Weissman, Myrna, PhD and Wickramaratne, Priya, PhD and Artama, Miia, PhD and Gingrich, Jay A., MD and Sourander, Andre, MD, PhD
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2016, Volume 55, Issue 5, pp. 359 - 366
Abstract Objective To investigate the impact of gestational exposure to selective serotonin reuptake inhibitors (SSRIs) on offspring neurodevelopment. Method... 
Pediatrics | Psychiatry | SSRI | ADHD | ASD | offspring depression | pregnancy | Follow-Up Studies | Prenatal Exposure Delayed Effects - epidemiology | Humans | Depressive Disorder - drug therapy | Maternal Exposure - statistics & numerical data | Anxiety Disorders - chemically induced | Young Adult | Autism Spectrum Disorder - epidemiology | Adult | Female | Registries | Depressive Disorder - chemically induced | Anxiety Disorders - drug therapy | Depressive Disorder - epidemiology | Attention Deficit Disorder with Hyperactivity - chemically induced | Autism Spectrum Disorder - chemically induced | Serotonin Uptake Inhibitors - adverse effects | Anxiety Disorders - epidemiology | Bipolar Disorder - drug therapy | Pregnancy | Adolescent | Finland - epidemiology | Bipolar Disorder - epidemiology | Prenatal Exposure Delayed Effects - chemically induced | Attention Deficit Disorder with Hyperactivity - epidemiology | Complications and side effects | Prenatal drug exposure | Pregnant women | Serotonin uptake inhibitors | Health aspects | Child psychopathology | Risk factors | Adolescence | Mental disorders | Hyperactivity | Mentally ill mothers | Antenatal | Medical diagnosis | Serotonin reuptake inhibitors | Psychotropic drugs | Antidepressants | Anxiety | Prenatal experience | Antidepressant drugs | Maternal depression | Serotonin | Attention deficit hyperactivity disorder | Anxiety-Depression | Depression | Autistic children | Autism | Progeny | Cohort analysis | Fetal exposure | Psychiatric disorders | Childbirth | Index Medicus | offspring | depression
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: A double-blind, placebo-controlled study
by Muscatello, Maria Rosaria A and Bruno, Antonio and Pandolfo, Gianluca and Micò, Umberto and Scimeca, Giuseppe and Romeo, Vincenzo Maria and Santoro, Vincenza and Settineri, Salvatore and Spina, Edoardo and Zoccali, Rocco A
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 04/2011, Volume 31, Issue 2, pp. 174 - 179
Based on the evidence that aripiprazole added to serotonin reuptake inhibitors (SRIs) or clomipramine in treatment-resistant obsessive-compulsive disorder... 
serotonin reuptake inhibitors | clomipramine | aripiprazole | obsessive-compulsive disorder | CONTROLLED TRIAL | ANXIETY | PSYCHIATRY | OPERATIONAL DEFINITIONS | FLUVOXAMINE | METHODOLOGICAL ISSUES | OLANZAPINE AUGMENTATION | PHARMACOLOGICAL-TREATMENT | ANTIPSYCHOTIC AUGMENTATION | PHARMACOLOGY & PHARMACY | SCALE | RISPERIDONE AUGMENTATION | Piperazines - administration & dosage | Clomipramine - administration & dosage | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Aripiprazole | Young Adult | Obsessive-Compulsive Disorder - psychology | Quinolones - administration & dosage | Obsessive-Compulsive Disorder - drug therapy | Serotonin Uptake Inhibitors - administration & dosage | Adult | Female | Aged | Drug Therapy, Combination | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights